Friedberg Ezra M's Form 4 filing
Pelthos Therapeutics Inc. (PTHS) · filed Nov 26, 2025
- Accession no.
- 0001753926-25-001831
- Filed
- Nov 26, 2025
- Trade date
- Nov 25, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $280.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Friedberg Ezra MCIK 0001679440 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | Common Stock | SSaleDisposed | −5,999 | $28.00 | −$167,972 | 34,001 | Indirect | |
| Nov 25, 2025 | Common Stock | SSaleDisposed | −2,000 | $28.14 | −$56,280 | 32,001 | Indirect | |
| Nov 25, 2025 | Common Stock | SSaleDisposed | −1 | $28.50 | −$28.5 | 32,000 | Indirect | |
| Nov 25, 2025 | Common Stock | SSaleDisposed | −2,000 | $28.01 | −$56,020 | 30,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.